Skip to main content
Smart Investors Daily
TC

NASDAQ · TCMD

Tactile Systems Technology, Inc.

Healthcare · Medical - Devices

$22.19

Down-$0.28 (-1.25%)

Updated Oct 7, 2026, 7:59 AM

SID Score

4.2/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
630.31M
P/E ratio
43.12
Dividend yield
0.00%
52-week range
$20.53 – $32.44
Volume
148.58K
Avg. volume
371.72K

Price performance · TCMD

TCMD price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 6, 2026

TCMD closed at $22.19 after 21 trading sessions, up 2.12% for the selected period.

Last close
$22.19
Period change
+2.12%
Period low
$21.71
Period high
$22.89
Daily close
View OHLC price history
TCMD OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 6, 2026$22.52$22.69$21.92$22.19148.58K
Oct 5, 2026$22.30$22.515$22.00$22.47352.81K
Oct 2, 2026$22.25$22.43$21.61$22.10252.31K
Oct 1, 2026$22.29$22.35$21.70$21.71205.88K
Sep 30, 2026$22.64$22.7271$22.28$22.29234.32K
Sep 29, 2026$22.80$22.90$22.26$22.53220.94K
Sep 28, 2026$22.69$23.30$22.675$22.82151.43K
Sep 25, 2026$22.77$22.905$22.37$22.73264.66K
Sep 24, 2026$22.45$22.97$22.45$22.89175.07K
Sep 23, 2026$22.60$22.72$22.08$22.43140.85K
Sep 22, 2026$22.855$23.23$22.55$22.68324.02K
Sep 21, 2026$22.37$23.08$22.12$22.85201.53K
Sep 18, 2026$22.29$22.67$22.10$22.20443.89K
Sep 17, 2026$22.43$22.65$21.99$22.56623.24K
Sep 16, 2026$22.52$22.96$22.13$22.17445.34K
Sep 15, 2026$22.48$22.63$22.25$22.51191.04K
Sep 14, 2026$22.40$23.00$22.31$22.57214.66K
Sep 11, 2026$22.68$22.73$22.00$22.40240.36K
Sep 10, 2026$21.79$22.345$21.64$22.32221.99K
Sep 9, 2026$21.56$22.165$21.405$22.02317.82K
Sep 8, 2026$21.54$21.928$21.2894$21.73397.16K

Latest TCMD news

The latest Smart Investors Daily articles mentioning TCMD.

TCMD research

Overview

Company profile and research snapshot.

Company profile

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$26.67
Implied upside
—
Analysts
11
TCMD recent ratings
DateFirmRatingTarget
Aug 11, 2026BTIGBuy—
May 21, 2026BTIGBuy—
May 7, 2026B. Riley SecuritiesBuy—
May 5, 2026BTIGBuy—
Feb 18, 2026B. Riley SecuritiesNeutral—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.